Jiangxi Copper Co Ltd Class A (600362)
Shanghai Stock Exchange · China · prices in CNY · close of 23 Oct 2026
Key indicators
| Last close | CNY 36.92 |
|---|---|
| 52-week range | 34.68 – 70.70 |
| Return, 1 month / 3 months | −17.1% / −18.1% |
| Return, 1 year / 3 years | −0.6% / +111.2% |
| Trend | Below its 200-day average |
| RSI (14) | 32 |
| Volatility (1 year) | 59.2% |
| Worst drawdown (1 year) | -48.5% |
| Average daily value traded | 2,415.06M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jiangxi Copper is a Chinese metals producer based in Nanchang, Jiangxi province. The company mines copper ore and smelts and refines it into copper products, and it also recovers gold, silver and sulphuric acid as by-products of its operations. Its customers are industrial manufacturers and metals traders who use copper in construction, electrical equipment and other manufacturing. Jiangxi Copper also trades metals and holds interests in related resource projects.
The shares are listed on the Shanghai Stock Exchange in China under the code 600362, and the price on this page is in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jiangxi Copper Co Ltd Class A (600362) trades on the Shanghai Stock Exchange in China. It last closed at CNY 36.92 on 23 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 1,297 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 0.6% and over the last three months it fell 18.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 34 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -22.3% | ||
| From 52-week high | -47.6% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -18.1% | ||
| 6-month return | -17.3% | ||
| 12-month return, skipping the last month | 20.0% | ||
| Stability (higher is calmer) | 29 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 59.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.5% | ||
| Liquidity | 97 · Strong | Trades actively. | |
| Average daily value traded | 2,415.06M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −6.4% |
|---|---|
| 1 month | −17.1% |
| 3 months | −18.1% |
| 6 months | −17.3% |
| 1 year | −0.6% |
| 3 years | +111.2% |
| 5 years | +59.3% |
Signals
| 50-day / 200-day average | 44.31 / 47.53 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.64 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Jul 2023 | CNY 0.5000 |
| 25 Jul 2022 | CNY 0.5000 |
| 20 Jul 2021 | CNY 0.1000 |
| 16 Jul 2020 | CNY 0.1000 |
| 26 Jul 2019 | CNY 0.2000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.